Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
TEANECK, N.J., May 08, 2017 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 22, 2017, to stockholders of record at the close of business on May 31, 2017.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For further information, please visit www.pahc.com.
Contact: Richard Johnson Chief Financial Officer, Phibro Animal Health Corporation +1 201-329-7300 [email protected]
